Back to Journals » Journal of Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma

ISSN: 2253-5969


Editor-in-Chief: Dr Ahmed Kaseb

The Journal of Hepatocellular Carcinoma is an international, peer-reviewed, open access journal.

The journal welcomes original research manuscripts, reviews, clinical trial reports, expert opinions and commentaries relating to all aspects of HCC, spanning from basic laboratory research through to clinical and translational research.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). 

 

Latest articles:

- 5 records -

CRISPR in Targeted Therapy and Adoptive T Cell Immunotherapy for Hepatocellular Carcinoma

Palaz F, Ozsoz M, Zarrinpar A, Sahin I

Journal of Hepatocellular Carcinoma 2024, 11:975-995

Published Date: 30 May 2024

A Post-International Gastrointestinal Cancers’ Conference (IGICC) Position Statements

Yalcin S, Lacin S, Kaseb AO, Peynircioğlu B, Cantasdemir M, Çil BE, Hurmuz P, Doğrul AB, Bozkurt MF, Abali H, Akhan O, Şimşek H, Sahin B, Aykan FN, Yücel İ, Tellioğlu G, Selçukbiricik F, Philip PA

Journal of Hepatocellular Carcinoma 2024, 11:953-974

Published Date: 29 May 2024

A Novel Nomogram to Predict Prognosis of Advanced Hepatocellular Carcinoma Treated with Intensity-Modulated Radiotherapy Plus Anti-PD1

He M, Liang C, Pang Y, Jiang M, Long M, Yao Z, Wang X, Zhang R, Wu Q, Liang S, Li J

Journal of Hepatocellular Carcinoma 2024, 11:913-925

Published Date: 22 May 2024


Read more articles